Outcome | 24 weeks | 48 weeks |
---|---|---|
Virological response < 50 copies/ml | ||
Viral load < 50 copies/ml | 6/7 (85.7) | 4/5 (80.0) |
Viral load ≥ 50 copies/ml | 11/26 (42.3) | 9/22 (40.9) |
Virological response < 200 copies/ml | ||
Viral load < 50 copies/ml | 7/7 (100.0) | 5/5 (100.0) |
Viral load ≥ 50 copies/ml | 18/26 (69.2) | 15/22 (68.2) |
CD4 change, cells/microl: median (IQR) | ||
Viral load < 50 copies/ml | 29 (14–48) | 8 (− 85–50) |
Viral load ≥ 50 copies/ml | − 6 (− 134–107) | − 16 (− 116–77) |
Patients stopping the regimen for any reason | ||
Viral load < 50 copies/ml | 0/10 (0) | 2/10 (20.0) |
Viral load ≥ 50 copies/ml | 8/29 (27.6) | 13/29 (44.8) |
Patients stopping the regimen due to treatment failure | ||
Viral load < 50 copies/ml | 0/10 (0) | 0/10 (0) |
Viral load ≥ 50 copies/ml | 4/29 (13.8) | 4/29 (13.8) |
Patients stopping the regimen due to toxicity | ||
Viral load < 50 copies/ml | 0/10 (0) | 0/10 (0) |
Viral load ≥ 50 copies/ml | 0/29 (0) | 0/29 (0) |